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1. Introduction 
The cholinergic receptor protein (AChR) from 
fish electric organ is a rather well-known protein 
(reviewed [ 11). Sequencing of its main subunit 
has started [2], its integration to the membrane phase 
is currently studied by various physical methods, and 
several of its conformational transitions have been 
identified and correlated with characteristic changes of 
membrane permeability (see [I]). Still, an essential 
question remains: 
Which one of the recently identified components 
of the subsynaptic membrane, polypeptide chains 
and/or lipids, is necessary and sufficient for the 
regulation of cationic permeability by acetyl- 
choline (ACh)? 
Since a genetic approach to this question is not as 
accessible with electric fish as it is with Drosophila 
[3], the method we have adopted [4] is to recon- 
stitute a functional ACh-regulator (or receptor- 
ionophore complex [I]) starting from chemically 
identified components in solution (reviewed IS]). 
Preliminary results indicated that the experiment 
was feasible starting from a complete detergent 
extract of purified AChR-rich membranes [6,7] or 
even after purification of the AChR-protein [8,9]. 
Abbreviations: ACh, acetylcholine; AChR, acetylcholine 
receptor; Dns-C,-Cho, (l-(5-dimethylaminonaphtalene) 
sulfonamido)n-hexanoic acid P-(N-trimethyl ammonium 
bromide); SDS, sodium dodecylsulphate; MF’TA, 
4-(N-maleimido) phenyltrimethylammonium; HTX, 
histionicotoxin 
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However, measurement of agonist-sensitive ion fluxes 
did not appear sufficient to establish the conditions 
of a complete recovery of the native properties of the 
ACh-regulator. We therefore attempted to ‘recon- 
stitute’, first, the binding properties of the membrane- 
bound AChR [lo-121 then, to re-investigate the 
regulation of ion fluxes under conditions where the 
native binding properties were preserved. 
The interconversion between high and low 
affinity states of the AChR protein and the effect of 
allosteric ligands like local anesthetics (see [ 11) on 
this transition were recovered under equilibrium 
conditions [ IO,1 1 ] and after rapid mixing [ 121 
starting from a detergent extract of purified AChR- 
rich membranes. These membranes contained several 
polypeptides: 
(1) The well identified 40 000 mol. wt (40 k) chain 
which carries the AChR-site [13]; 
(2) A few minor polypeptides of app. mol. wt 50 k 
and 65 k; 
(3) A polypeptide chain of app. mol. wt 43 k [14, 
151. 
The 43 k protein can be removed from the AChR-rich 
membranes by alkaline extraction without interfering 
with the allosteric properties of the AChR protein 
and in particular its sensitivity to local anesthetics 
]161. 
We present here a method which f&rlly leads to 
the reconstitution of carbamylcholine sensitive ion 
fluxes. Under these conditions the allosteric properties 
of the AChR-protein tested by rapid mixing experi- 
ments and the binding of a radioactive anesthetic are 
preserved in the absence of the 43 k protein. 
181 
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2. Methods 
2.1. The reconstitution cycle 
The AChR rich membranes were purified from 
fresh electric organ from Torpedo marmorata as in 
[ 171 and, in general, stored in liquid nitrogen. Before 
use, the membranes were thawed, diluted to -5 mg 
protein/ml and supplemented with trace amounts of 
1251-labelled a-bungarotoxin; then, 3 ml of suspension 
were centrifuged at 22 000 rev./min for 13 h in a 
Beckman SW27 rotor on a 37 ml 35-41% (w/w) con- 
tinuous sucrose gradient and the fractions at 
37-39% (w/w) sucrose pooled as ‘purified mem- 
branes’. 
The purified membranes were depleted from the 
43 k protein following the method in [ 161 with the 
following modifications. The suspension was diluted 
to 20% (w/w) sucrose, 0.5-l mg protein/ml and 
adjusted to pH 11 .O with 1 N NaOH. After 45 min, 
the membrane suspension was layered on a 25% (w/w) 
sucrose cushion adjusted at pH 11 and centrifuged at 
100 000 X g for 2 h. After centrifugation, the 43 k 
protein remained in solution and the 43 k depleted 
membranes formed a pellet. The pellet was resus- 
pended in a small volume of buffer I (100 mM NaCl, 
10 mM Na-phosphate buffer (pH 7.4) 0.02% NaNs) 
and adjusted to pH 7.5 with 1 M Na-phosphate buffer 
(pH 6.7) (2, 25 mM final cont.) yielding the ‘alkaline- 
treated membranes’. 
The suspension of alkaline-treated membranes was 
supplemented first with 2-mercaptoethanol to 6%0 
final cont., then with 40% (w/w) Na-cholate to yield 
3% final cont. (w/w). After shaking for 45 s at room 
temperature, the mixture was diluted 3 times with 
buffer I and centrifuged for 20 min at 100 000 X g in 
a rotor 65 of a Beckman ultracentrifuge to pellet the 
insoluble material. The supernatant was referred to as 
the ‘soluble extract’. 
The detergent was separated from the solution of 
protein by filtration on a Sephadex G-50 column 
prepared in a 10 ml plastic syringe and equilibrated 
with Torpedo Ringer’s solution. The fractions of the 
excluded volume contained all the AChR and were 
pooled as the ‘reconstituted AChR’. 
Alternatively, a dialysis method similar to that in 
[7] was used. A mixture of 10% asolectin and 10% 
cholate, in buffer I was added to 100-500 ~1 of 
membrane fragments (-10 PM o-toxin binding sites) 
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to obtain a final 3% cholate concentration; 3-6°/oo 
2-mercaptoethanol could be added at this stage. After 
stirring for 30-60 s at room temperature, the mix- 
ture was diluted to 1% cholate with buffer I and 
centrifuged as above. The supernatant was dialysed 
-24 h against 500-1000 vol. of deaerated buffer I in 
Spectra/Par 2 dialysis tubing (mol. wt cut off 10 000) 
under a nitrogen atmosphere. 
2.2. Stopped jlow experiment with Dns-C6-Cho 
Rapid kinetic experiments were carried out in a 
Gibson-Durrum stopped-flow rapid mixing apparatus 
equipped for fluorescence detection. Fluorescence was 
excited at 290 nm using a 450 W Osram Xenon lamp and 
a grating monochromator (Jobin Yvon HRS 2); 90” 
fluorescence in the observation cell (quartz tube 
2 mm diam. 18 mm length) was monitored with an 
Hamamatsu R 376 photomultiplier using a high pass 
filter (540 nm cut). Single shot fluorescence signals 
were digitally stored in a Tracer NS 570 (12 bits 
1024 points) and plotted with a X-Y recorder. The 
traces were analysed with a X-Y Numonics graphic 
analyser on line with a Wang 2200 computer to which 
were given from 20-30 points/curve; the experimental 
traces were fitted using a non-linear iterative regression 
program (least square fit criterion) by mono- or 
multiexponentials, and both amplitudes and rate 
constants determined. 
2.3. Equilibrium binding of / 3H]trimethisoquin 
Binding of [3H]trimethisoquin was measured by a 
centrifugation method using a Beckman Airfuge and 
polyethylene tubes. The AChR containing sample was 
diluted in Torpedo physiological solution (250 mM 
NaCl, 5 mM KCl, 4 mM CaCl, ,2 mM MgC12 and 5 mM 
Na-phosphate (pH 7.0)) to 3-4 E.IM in a-bungarotoxin 
binding sites, 70 ~1 incubated with [3H]trimethisoquin 
(0.02 Ci/mmol) for 60 min and centrifuged at 
130 000 X g for 15 min; 10 ~1 duplicate aliquots taken 
before and after centrifugation were counted in 4 ml 
Bray’s scintillation medium. 
2.4. Ion jluxes 
Agonist-dependent influx of 22Na’ was measured 
on these preparations by an adaptation of the efflux 
method in [ 181. In a typical experiment 5 ~1 carrier- 
free “NaCl in water were added at 0°C at time zero 
to 100 ~1 of reconstituted material; 10 ~1 aliquots 
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were taken at increasing times, diluted into 5 ml ice- 
cold buffer and immediately filtered upon HAWP 
Millipore filters;after washing with 2 X 10 ml ice-cold 
buffer, the filters were placed into vials and counted 
for y emission in a CG 30 Intertechnique counter. 
Agonists were added as concentrated solutions, the 
resulting dilution factor being usually 1 or 2%; the 
same volume of buffer was added in control experi- 
ments. 
2.5 . Polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis was done 
with 1.1 mm thick, 10% acrylamide slab gels by the 
method in [ 171. Destained gels were scanned with a 
Vernon gel scanner. 
2 6. Chemicals 
Dns-C6Cho was a gift of Dr G. Waksman, M. C. 
Fournie-Zaluski and B. Roques who synthesized it; 
the details of the procedure for synthesis are given 
in [19]. rz51-labelled a-bungarotoxin was from NEN; 
prilocaine hydrochloride and trimethisoquin 
(l-/3-trimethylaminoethoxy) 3-n-butylisoquinoline 
hydrochloride) were a gift from Lab. Roger Bellon 
(France); Na cholate (analytical grade) was from 
Merck. ‘*NaCl was from the Radiochemical Centre, 
Amersham. [3H]Trimethisoquin was synthesized by 
G. Waksman and B. Roques and tritiated in 
Dr B. Pichat’s lab. at CEA Saclay. Histrionicotoxin 
was a gift of Dr G. Kato. Asolectin was from 
Associated Concentrates (USA). 
3. Results and discussion 
3.1. The reconstitution cycle 
Three critical properties of the ACh-regulator have 
been monitored during the reconstitution cycle: 
(1) The rapid binding kinetics of a fluorescent 
agonist, Dns-C6 Cho, recorded in a Gibson- 
Durrum stopped-flow apparatus equipped for 
fluorescence detection; 
(2) The binding of a radioactive local anesthetic 
[3H]methyl-trimethisoquin; 
(3) The regulation of ion fluxes through lipid vesicles 
containing the AChR. 
Four preparations of the AChR were used (see 
section 2.1.): 
(1) 
(2) 
The purified membranes, with a specific activity 
of 3-4 pm01 of ‘2sI-labelled cu-bungarotoxin 
sites/g protein (table I), yielded, after electro- 
phoresis in one dimension on SDS-polyacrylamide 
gels, two dominant polypeptide bands present in 
approximately equal amounts (see [ 171): the 40 k 
chain which can be covalently labelled by 
[3H]MPTA Karlin’s affinity reagent of the AChR 
site [13] and the 43 k chain. The 50 k and 66 k 
bands were systematically observed in most of 
the preparations, but in variable proportions and 
in small quantities. 
Treatment of the purified membranes at pH 11 
yielded the alkaline-treated membranes, which, in 
agreement with the findings of Neubig et al. [ 161, 
were depleted of the 43 k protein but still contained 
Table 1 
AChR-sites and local anesthetic binding sites in the reconstitution cycle 
‘2SI-labelled cY-bungarotoxin [3H]Trimethisoquin [3H]Trimethisoquinsites over 
binding sites binding sites “‘1-1abelled a-bungarotoxin 
&mol/g protein) (rmol/g protein) sites 
Purified membranes 3.8 
Alkaline-treated 
membranes 6.9 
Reconstituted AChR 8.0 
2.6 0.68 
5.3 0.77 
6.2 0.77 
Saturable [ ‘H]trimethisoquin binding sites were determined (see section 2) in the presence of carbamyl- 
choline (5 X lo-’ M). The amounts of [“Hltrimethisoquin bound in the presence and in the absence of 
HTX (10e4 M) were plotted as a function of free [3H]trimethisoquin concentration: the difference 
between the two curves reaches a plateau which gives the concentration of local anesthetic binding 
sites. ‘*SI-labelled cu-bungarotoxin binding sites were measured with a Sephadex G-75 column as in [ 171 
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the 40 k, 50 k and 66 k bands. The specific activity 
of these membranes in r*’ I-labelled a-bungarotoxin 
sites ranged between 6-8 pmol/g protein. 
The soluble extract was obtained by adding Na- 
cholate to the alkaline-treated membranes to 3% 
final cont. (w/w). The mixture was then diluted 
to 1% and centrifuged at 100 000 X g for 20 min 
to pellet the insoluble material. The polypeptide 
composition (fig.1) of the supernatant, in 
general, did not differ from that of the alkaline 
treated membranes. 
The elimination of the detergent from the soluble 
extract by filtration on a Sephadex G-50 column 
or by dialysis yielded two different states of the 
AChR depending whether or not the extract was 
supplemented with additional lipids (asolectin). 
In the first instance, the preparation was referred 
to as ‘reconstituted AChR’, in the second as 
‘reconstituted vesicles’. The polypeptide com- 
position and specific activity of these two 
4OK - 
Migration 
Fig.1. Polypeptide composition of the ‘soluble extract’ 
analyzed by SDS-polyacrylamide gel electrophoresis as in 
section 2. T.D., tracking dye. 
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preparations was identical to that of the soluble 
extract. The yield in ‘251-labelled a-bungarotoxin 
sites throughout the reconstitution cycle was 
- 60%. 
3.2. Rapid kinetics of interaction of Dns-C6-Cho with 
the AChR-site in the reconstitution cycle 
In fig.2 are presented stopped-flow traces obtained 
by rapid mixing of the fluorescent agonist Dns-C6-Cho 
[ 191 with the purified alkaline-treated membranes or 
with the reconstituted AChR. In all these three 
instances, the recordings apeear rather similar. The 
three relaxation processes, fast, intermediate and 
slow, identified with the native membranes [20] 
were observed, and interpreted in terms of the 
interactions of Dns-C6-Cho with high and low 
affinity binding sites and of an interconversion of the 
low to the high affinity sites in the presence of this 
agonist. Accordingly, after reconstitution, a significant 
fraction of the AChR-sites were in a low affinity state 
(-70%) and could undergo the slow conformational 
transition previously related to the ‘desensitization’ of 
the membrane response to cholinergic agonists 
(reviewed [ 11). 
Local anesthetics and other non-competitive 
blockers of the physiological response to ACh have 
been shown to modify the kinetic parameters of 
Dns-C6-Cho interaction with purified AChR-rich 
membranes in the following manner: they increase 
the amplitude of the rapid relaxation process and 
the rate constants of the intermediate and slow 
processes [20]. Figure 2 shows that the same effects are 
observed in the case of trimethisoquin with alkaline- 
treated membranes and reconstituted AChR. Con- 
clusively, and in agreement with the findings of Neubig 
et al. [ 161, the 43 k protein which is missing in these 
two preparations, does not take part in the allosteric 
interaction between local anesthetic binding site and 
AChR-site. 
3.3. Equilibrium binding of [ 3H]trimethisoquin in the 
reconstitution cycle 
The binding site for local anesthetics and non 
competitive blockers has been labelled by radioactive 
derivatives of potent local anesthetics such as 
[3H]trimethisoquin [21,22]. Binding curves of 
[3H]trimethisoquin have been established with the 
three particulate preparations described in the recon- 
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108 
purified 
membranes 
4Omc 
+ PO PM trimethisoquin 
106 
alkaline treated 
membranes 
101 
l I 
4Om6 
+ 20 yM trimethiioquin 
109 
reconstituted 
AChR 
+ 20 VM trimethisoquin 
Fig.2. Single-shot races of stopped-flow experiments:change of fluorescence intensity after rapid mixing of a solution of Dns-C, - 
Cho with purified membranes (top), alkalinetreated membranes (middle) and reconstituted AChR (bottom); effect of 
tr~e~~ujR. hex = 290 nm, kern > 540 nm (cf. section 2); 1:l mixing of a solution of Dns-C, -Cho in Torpedo saline solution 
(3 rMf with purified membranes, alkaline-treated membranes and reconstituted AChR (% 0.4 MM o-toxin binding sites) in 
Torpedo saline solution in the absence (left) or presence (right) of 20 PM trimethisoquin; rapid relaxation processes are 
represented on expanded time scales. 
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stitution cycle in the presence and in the absence of 
histrionicotoxin (HTX). Table 1 shows that with the 
native membranes and in presence of the cholinergic 
agonist carbamylcholine, the number of high affinity 
binding sites from which [3H]trimethisoquin is dis- 
placed by HTX (see [21,22]) was -0.7-times the 
number of ‘2SI-labelled a-bungarotoxin sites. 
Interestingly, the same values were found with the 
alkaline-treated membranes and the reconstituted 
AChR. From a series of experiments carried out with 
detergent solubilized 43 k protein and quinacrine 
it was inferred that the 43 k protein bound local 
anesthetics [14]. The present data confirm that these 
sites are not the regulatory sites involved in the 
allosteric interaction between local anesthetics and 
cholinergic agonists. 
3.4. Recovery of agonist-sensitive ion fluxes 
When the last step of the reconstitution cycle was 
carried out in the presence of a complex lipid mixture 
such as asolectin, closed vesicles were obtained. 
The rapid kinetics of interaction of Dns-Cd-Cho with 
the AChR protein integrated to these reconstituted 
vesicles did not significantly differ from those 
obtained when the reconstitution step was performed 
in the absence of exogenous lipids. As shown in fig.3, 
these vesicles exhibit a rather low permeability to 
**Na+, but carbamylcholine markedly enhanced the 
Ll 
Fig.3. Concentrated ‘*NaCl was added at 1=0 to a suspension 
of reconstituted vesicles preincubated (A) or not (0) with a 
-2O-fold excess of a-bungarotoxin; 20 ~1 aliquots were diluted 
into ice-cold buffer at the times indicated and rapidly filtered. 
At t=lO min (arrow), the remnant of the suspension was 
supplemented (*,A) or not (0) with enough concentrated car- 
bamylcholine to give 4 X 10m4 M final cont. 
influx of **Na’ and this response was abolished by 
preincubation with an excess of Lu-bungarotoxin. The 
effect of carbamylcholine on *‘Na+ influx was 
observed with the 7 preparations tested and there- 
fore, appears reproducible. 
Since the 40 k chain is largely the dominant poly- 
peptide in the reconstituted material, the most simple 
interpretation of the present data is that the 40 k 
chain carries both the ACh-receptor site and the ACh- 
ionophore. However, small amounts (< 10%) of the 
50 k and 66 k chains were still present in the recon- 
stituted vesicles; a small number of functional 
receptor-ionophore complexes per vesicle might be 
sufficient to give a measurable influx of **Na+ and the 
‘contaminating’ peptides might precisely be part of 
these complexes. This possibility has to be considered 
and experimentally tested. Future work should also 
include investigations on an eventual role of the 
endogenous lipids which remain associated with the 
AChR protein during the reconstitution cycle. 
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